Posted by Michael Wonder on 23 Jan 2024
Remdesivir and the combination of tixagevimab and cilgavimab for the treatment of patients with COVID-19 disease
18 January 2024 - NICE has published additional draft guidance on the use of remdesivir and the combination of tixagevimab and cilgavimab in the NHS in England.
Remdesivir is recommended as an option for the treatment of certain patients with COVID-19 disease.
Tixagevimab and cilgavimab is not recommended for the treatment of adults with COVID-19 disease who do not need supplemental oxygen and who have an increased risk of progression to severe COVID-19.
